JEFFREY HUGHES: Open Payments
NPI 1841799616 · BELZONI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 20 payments from 8 companies in 2025. Trend: 2023 $631 · 2024 $558 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $285 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Lundbeck LLC | 5 | $118 |
| ABBVIE INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Amgen Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Ozempic, AIRSUPRA, REXULTI, Rybelsus, VRAYLAR, TRELEGY ELLIPTA, OTEZLA, NEXLETOL.
Industry payments across MS — which companies pay providers there.
